Wartstick Plantar

Description

Wart STICK® PLANTAR is a solid-stick wart remover formulated with 40% salicylic acid, designed for the effective treatment of plantar warts. This maximum strength formulation offers a stronger and painless alternative to traditional liquid and freezing methods. The product is specifically sized for larger plantar warts, ensuring ease of application. Each unit contains a net weight of 0.34 oz (9.6 g).

Uses and Indications

This drug is indicated for the removal of plantar warts. Plantar warts are characterized by their specific location on the bottom of the foot, tenderness upon pressure, and disruption of the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to application. For enhanced efficacy, the area may be soaked in warm water for approximately 5 minutes. After soaking, it is essential to dry the area completely.

A thin layer of the product should be applied directly to each wart, ensuring that the product does not come into contact with the surrounding skin. Following application, the affected area must be covered with a clean bandage to protect it.

This procedure may be repeated daily as necessary until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

• Diabetic patients should not use this product due to potential complications associated with their condition.

• Application on irritated, infected, or reddened skin is contraindicated to prevent exacerbation of the condition.

• Patients with poor blood circulation should avoid use, as it may worsen their circulatory issues.

• The product should not be applied to warts with hair growing from them, as this may lead to adverse effects.

• Use on moles or birthmarks is contraindicated to avoid potential irritation or complications.

• Application on the face, genitals, or mucous membranes is not recommended due to increased sensitivity and risk of adverse reactions.

Warnings and Precautions

For external use only. This product is contraindicated in individuals with diabetes, as well as those with poor blood circulation. It should not be applied to irritated, infected, or reddened skin, nor should it be used on warts with hair growing from them, moles, or birthmarks. Additionally, application to the face, genitals, or mucous membranes is prohibited.

Healthcare professionals should advise patients to discontinue use and seek medical advice if irritation occurs or if discomfort persists. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients should be aware that the product is for external use only. It is contraindicated in individuals with diabetes, as well as those with irritated, infected, or reddened skin. Additionally, the product should not be applied to areas with poor blood circulation, warts with hair growing from them, moles, or birthmarks. It is also not recommended for use on the face, genitals, or mucous membranes.

In the event of irritation or persistent discomfort, patients are advised to discontinue use and consult a healthcare professional. Furthermore, it is essential to keep the product out of reach of children and pets. If ingested, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Wartstick Plantar (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children and pets. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is currently no information available regarding the use of this medication during pregnancy. Safety concerns, dosage modifications, and special precautions for pregnant patients have not been established. Healthcare professionals should consider the lack of data when prescribing this medication to women of childbearing potential and weigh the potential risks and benefits. It is advisable to monitor any pregnant patients closely and to discuss the implications of treatment with them.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children and pets to prevent accidental ingestion. It is important to emphasize the potential risks associated with swallowing the medication. In the event of accidental ingestion, patients should be instructed to seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring the safety and well-being of both patients and their families.

Storage and Handling

The product is supplied in a configuration that requires the cap to be replaced after use. It should be stored at room temperature. No specific temperature range or container requirements are indicated, but proper handling includes ensuring the cap is securely replaced to maintain product integrity.

Additional Clinical Information

The product is administered topically, with the procedure to be repeated daily as needed until the wart is removed, for a maximum duration of 12 weeks. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Wartstick Plantar, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)